Video Experimental Relacionado

Updated: Sep 9, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

[Estado actual y progreso de la investigación en economía de la salud sobre la inmunoterapia específica de alérgenos]

Qianxue Hu¹, Liyue Li¹, Ziyi Long¹

¹Department of Otolaryngology Head and Neck Surgery，Tongji Medical College Affiliated Union Hospital，Huazhong University of Science and Technology，Wuhan，430022，China.

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery

|September 3, 2025

Resumen

La inmunoterapia específica de alérgenos (AIT) ofrece importantes beneficios económicos a largo plazo para las enfermedades alérgicas, a pesar de los costos iniciales. La investigación futura debe centrarse en la reducción de estos costes y en la estandarización de las evaluaciones para obtener datos económicos más amplios.

Área de la Ciencia:

Alergia e inmunología
Economía de la salud
Salud pública

Sus antecedentes:

Las enfermedades alérgicas como la rinitis y el asma suponen una carga socioeconómica significativa.
La inmunoterapia específica para alérgenos (AIT) es un tratamiento reconocido para estas afecciones.
Las evaluaciones económicas de la salud de AIT son cada vez más importantes.

Objetivo del estudio:

Revisar el estado actual de la investigación económica y el progreso de AIT.
Para discutir la carga socioeconómica de la rinitis alérgica.
Analizar los estudios y metodologías de economía de la salud para AIT.

Principales métodos:

Revisión de la literatura de las evaluaciones económicas de la salud de AIT.
Análisis de los estudios sobre la carga socioeconómica de la rinitis alérgica.
Examen de las metodologías utilizadas en la investigación económica del AIT.

Principales resultados:

AIT tiene altos costos iniciales, pero produce importantes beneficios económicos a largo plazo.
Los beneficios incluyen una menor utilización de la atención médica, una mejor calidad de vida y menos dependencia de medicamentos.
La evidencia económica apoya a AIT para el manejo de enfermedades alérgicas.

Conclusiones:

AIT presenta un argumento sólido para el ahorro de costos y los beneficios para la salud a largo plazo en el manejo de enfermedades alérgicas.
La investigación futura debería dar prioridad a la reducción de los costes iniciales del AIT.
Las herramientas de evaluación estandarizadas y los estudios transnacionales son las direcciones clave para el futuro.

Palabras clave:

Inmunoterapia con alérgenos rhinitis alérgica economía de la salud

Más Videos Relacionados

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

Videos de Conceptos Relacionados

Allergic Reactions

Allergic Reactions

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

Hypersensitivities

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...